相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
低温
- 保质期:
详见说明
- 库存:
99
- 供应商:
上海圻明生物
- 规格:
50次
SARS-CoV-2冠状病毒(新冠病毒)S基因RT-PCR试剂盒上海圻明生物优势供应。更多产品资料欢迎免费咨询。
One of the many important uses of PCR technology is that it can be used to label DNA probes with high specific activity. PCR technology has high specificity, and can synthesize probe DNA fragments in quantities within 1~2h if [α-32P]dNTP or other markers are added to the substrate
dNTPs, the probe DNA can be well labeled during DNA synthesis, and the incorporation rate of the marker can be as high as 70%~80%. Therefore, PCR labeling technology is particularly suitable for large-scale detection and non-radiolabeling. The disadvantage of this method is that a specific pair of PCR primers is synthesized.
Labeling can also be achieved by using small fragments prepared from probe DNA as primers.
Solution preparation
1. Prepare a stock solution
Unless otherwise stated, all unused stock solutions should be divided into disposable aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles.
1.1* Acid Stock Solution (125X):
Add 20 μL DMSO to *ate (component B) to make a 125X* acid stock solution.
2. Prepare standard solutions
*Salt standard solution
Add 50 μL of 1 mM KH2PO4 (Component C) to 950 μL of deionized water or enzyme reaction buffer to give a 50 μM * saline standard solution (PS7). A 50 μM * saline standard solution (PS7) was taken and serially diluted 1:2 to obtain a serially diluted phosphate standard with deionized water or enzyme reaction buffer.
3. Prepare a working solution
Add 20 μL of 125X* stock solution to 2.5 mL of sterile H2O and mix well to make a working solution of *salt. Avoid potential Pi contamination. Note: Avoid direct exposure of *salts (component B) to light. Due to the high sensitivity of this assay to Pi, it is extremely important to use Pi-free labware and reagents.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Science:老药新用,研究发现癌症药物马赛替尼可有效对抗
了它们的 EC50(降低 50% 感染率所需要的药物浓度)以及对细胞增殖的影响。并进一步筛选能够抑制新冠病毒 SARS-CoV-2 的小分子药物,实验结果显示,包括马赛替尼在内的 20 个药物显示出较好的抑制新冠病毒活性的作用。图片来源:Science蛋白酶 3CL 是新冠病毒复制过程中不可替代的蛋白酶,并且在多种冠状病毒之间保守,同时靶向 3CL 蛋白酶的抗病毒药物可以有效避免因 SPIKE 蛋白突变而导致药物失效的可能性。因此,后续研究人员将关注点放在了对新冠病毒主要蛋白酶 3CL 有抑制效果的小分
中科院高福院士课题组 2020 年发表了哪些重要的研究成果?
年,高福院士和他带领的团队,在传染病研究领域尤其是对新冠病毒的研究,获得了丰厚的研究成果。其带领团队先后研发出新冠病毒治疗性中和抗体和疫苗,在新冠病毒溯源、跨种传播机制方面也有着突出的研究成果。 图片来源:Web of Science以下,小编选取了其中 10 项,介绍高福院士及其团队在 2020 年最有代表性的研究成果。 1、揭示 MERS-CoV 与 7 种蝙蝠 CD26 结合的分子基础DOI: 10.1128/JVI.01387-19自 2012 年鉴定出中东呼吸综合征冠状病毒(MERS
日前,北京大学生命科学学院魏文胜课题组在 Cell 杂志上在线发表题为“Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants”的研究论文。 魏文胜团队首先建立了体外高效制备高纯度环状 RNA 的技术平台,针对新型冠状病毒及其变异株,设计了编码新冠病毒刺突蛋白(Spike)受体结构域(RBD)的环状 RNA 疫苗。 该项研究中制备的针对新冠病毒德尔塔变异株的环状 RNA 疫苗(circRNARBD
技术资料暂无技术资料 索取技术资料





